Skip to main content

Evolution and Human History, Part I

Image result for Nicholas Wade

My recent reading has included A Troublesome Inheritance (2014) by Nicholas Wade.

Wade is an experienced science journalist -- he is a graduate of King's College, Cambridge, was deputy editor of Nature, and before going freelance he was both a reporter and an editor at The New York Times, where  he wrote frequently about scientific and environmental matters.

His book has the subtitle "Genes, Race, and Human History," which suffices to reveal how fraught is the subject matter. The point he wants to make is that biological evolution continues to change the human genome, and does so at time scales which are relevant to an understanding of history, not just dim pre-history. Evolution by natural selection isn't just about the fossil "Lucy" and her peers. It's about the fellow or gal in the mirror this morning.

Evolutionary psychologists, he says, commonly "teach  that the human mind is adapted to the conditions that prevailed at the end of the last ice age, some 10,000 years ago." But that is an arbitrary demarcation. There have been changes in innate human behavior (mark the word "innate" -- his word) -- subsequent to that. Only 3,000 years ago, for example, "Tibetans evolved a genetic variant that lets them live at high altitudes."

This does open up the discussion of race, not as a "social construct" but as a biological fact. Why? Because much longer ago than 3,000 three main sub-groupings of humans had become geographically divided: those of sub-Saharan Africa, of Eurasia from the Himalayas west, and of Asia from the Himalayas east. Those Tibetans notwithstanding, the highest mountains on the planet served as a powerful barrier to genetic mixing, as did the Sahara desert. So it seems a priori reasonable to suppose that to the extent evolution as been active since the geographical spread of the human race across these natural boundaries, that evolution has taken somewhat disparate paths.

The back of the book includes a blurb from Edward O. Wilson, praising Wade for celebrating "genetic diversity as a strength of humanity."

I'll say some more about this book and its thesis tomorrow.


Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…